Medicine
Oncology

Prostate cancer
Integrative medicine, Common medications, Nutrition


Home > Disciplines > Medicine > Oncology > Prostate cancer > Integrative medicine



CONTENTS



OVERVIEW


ALLOPURINOL


ASPIRIN
Aspirin and biochemical recurrence
Aspirin and radiotherapy
Aspirin and mortality
Prevention of the transformation to cRPC


CORTICOSTEROIDS


MELATONIN


METFORMIN


NUTRITION AND DIETARY SUPPLEMENTS


PHYSICAL ACTIVITY


PREVENTION OF PROGRESSION


PROTEINS


STATINS
MORTALITY
RECURRENCE




Books
PDQ CANCER INFORMATION SUMMARIES





OVERVIEWS


.

Abrams DI et al, PDQ Integrative, Alternative, and Complementary Therapies Editorial Board.
Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2019 Jan 14.
Source | Sections | Book | Similar articles




Stopsack KH, Greenberg AJ, Mucci LA.
Common medications and prostate cancer mortality: a review.
World J Urol. 2017 Jun;35(6):875-882. doi: 10.1007/s00345-016-1912-5. Epub 2016 Aug 4.
Source | Full text | Similar articles



Obesity, Inflammation, and Prostate Cancer


.

Fujita K, Hayashi T, Matsushita M, Uemura M, Nonomura N.
Obesity, Inflammation, and Prostate Cancer.
J Clin Med. 2019 Feb 6;8(2). pii: E201. doi: 10.3390/jcm8020201.
Source | Full text | Similar articles



ALLOPURINOL


.

Kukko V, Kaipia A, Talala K, Taari K, Tammela TLJ, Auvinen A, Murtola TJ.
Allopurinol and the risk of prostate cancer in a Finnish population-based cohort.
Prostate Cancer Prostatic Dis. 2019 Jan 29. doi: 10.1038/s41391-019-0129-2. [Epub ahead of print]
Source | Full text | Similar articles



.

Shih HJ, Kao MC, Tsai PS, Fan YC, Huang CJ.
Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study.
Prostate Cancer Prostatic Dis. 2017 Apr 11. doi: 10.1038/pcan.2017.14. [Epub ahead of print]
Source | Full text | Similar articles



ASPIRIN


.

Bilani N, Bahmad H, Abou-Kheir W.
Prostate Cancer and Aspirin Use: Synopsis of the Proposed Molecular Mechanisms.
Front Pharmacol. 2017 Mar 21;8:145. doi: 10.3389/fphar.2017.00145. eCollection 2017.
Source | Full text | Similar articles



.

Coyle C, Cafferty FH, Rowley S, MacKenzie M, Berkman L, Gupta S, Pramesh CS, Gilbert D, Kynaston H, Cameron D, Wilson RH, Ring A, Langley RE; Add-Aspirin investigators..
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours.
Contemp Clin Trials. 2016 Nov;51:56-64. doi: 10.1016/j.cct.2016.10.004. Epub 2016 Oct 21.
Source | Full text | Similar articles



.

Downer MK, Allard CB, Preston MA, Gaziano JM, Stampfer MJ, Mucci LA, Batista JL.
Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.
Eur Urol. 2017 Feb 9. pii: S0302-2838(17)30069-6. doi: 10.1016/j.eururo.2017.01.044. [Epub ahead of print]
Source | Full text | Similar articles



.

Skriver C, Dehlendorff C, Borre M, Brasso K, Sørensen HT, Hallas J, Larsen SB, Tjønneland A, Friis S.
Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study.
Cancer Causes Control. 2016 Sep;27(9):1067-79. doi: 10.1007/s10552-016-0785-7. Epub 2016 Aug 9.
Source | Full text | Similar articles



.

Zhao X, Xu Z, Li H.
NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis.
Sci Rep. 2017 May 12;7(1):1875. doi: 10.1038/s41598-017-01644-0.
Source | Full text | Similar articles



.

Zhou CK, Daugherty SE, Liao LM, Freedman ND, Abnet CC, Pfeiffer R, Cook MB.
Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.
Cancer Prev Res (Phila). 2017 May 15. doi: 10.1158/1940-6207.CAPR-17-0033. [Epub ahead of print]
Source | Full text | Similar articles



Aspirin and biochemical recurrence


.

Hao Q, Gong H, Zong H, Huang S, Wang T, Zhou Y, Zhang Y, Zhang Y.
Aspirin use improves the biochemical control of prostate cancer in Chinese men.
J BUON. 2018 Nov-Dec;23(6):1803-1808.
Source | Full text | Similar articles



Aspirin and radiotherapy


.

Mascan B, Marignol L.
Aspirin in the Management of Patients with Prostate Cancer Undergoing Radiotherapy: Friend or Foe?
Anticancer Res. 2018 Apr;38(4):1897-1902.
Source | Full text | Similar articles



Aspirin and mortality


.

Skriver C, Dehlendorff C, Borre M, Brasso K, Larsen SB, Dalton SO, Nørgaard M, Pottegård A, Hallas J, Sørensen HT, Friis S.
Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study.
Ann Intern Med. 2019 Mar 5. doi: 10.7326/M17-3085. [Epub ahead of print]
Source | Abstract | Similar articles



Prevention of the transformation to castration-resistant prostate cancer


.

Yang L, Chen Y, Tang Z, Xue W, Qiu S, Tan P, Wei Q.
Aspirin and levofloxacin for the prevention of the occurrence of prostate cancer or transformation to castration-resistant prostate cancer: a two-part, open-label, randomised, controlled study.
Lancet. 2016 Oct 1;388 Suppl 1:S85. doi: 10.1016/S0140-6736(16)32012-8.
Source | Full text | Similar articles



CONCOMITANT USE OF STATINS


.

He Y, Huang H, Farischon C, Li D, Du Z, Zhang K, Zheng X, Goodin S.
Combined effects of atorvastatin and aspirin on growth and apoptosis in human prostate cancer cells.
Oncol Rep. 2017 Feb;37(2):953-960. doi: 10.3892/or.2017.5353. Epub 2017 Jan 4.
Source | Full text | Similar articles



.

Ma Y, Brusselaers N.
Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk.
Prostate Cancer Prostatic Dis. 2017 Dec 19. doi: 10.1038/s41391-017-0021-x. [Epub ahead of print]
Source | Full text | Similar articles



CORTICOSTEROIDS


.

Kübler H.
[Corticosteroids in the management of advanced prostate cancer].
Urologe A. 2016 Nov 22. [Epub ahead of print] German.
Source | Full text | Similar articles



MELATONIN


.

Calastretti A, Gatti G, Lucini V, Dugnani S, Canti G, Scaglione F, Bevilacqua A.
Melatonin Analogue Antiproliferative and Cytotoxic Effects on Human Prostate Cancer Cells.
Int J Mol Sci. 2018 May 18;19(5). pii: E1505. doi: 10.3390/ijms19051505.
Source | Full text | Similar articles



.

Li Y, Li S, Zhou Y, Meng X, Zhang JJ, Xu DP, Li HB.
Melatonin for the prevention and treatment of cancer.
Oncotarget. 2017 Mar 18. doi: 10.18632/oncotarget.16379. [Epub ahead of print]
Source | Full text | Similar articles



.

Liu VWS, Yau WL, Tam CW, Yao KM, Shiu SYW.
Melatonin Inhibits Androgen Receptor Splice Variant-7 (AR-V7)-Induced Nuclear Factor-Kappa B (NF-κB) Activation and NF-κB Activator-Induced AR-V7 Expression in Prostate Cancer Cells: Potential Implications for the Use of Melatonin in Castration-Resistant Prostate Cancer (CRPC) Therapy.
Int J Mol Sci. 2017 May 31;18(6). pii: E1130. doi: 10.3390/ijms18061130.
Source | Full text | Similar articles



METFORMIN


.

Coyle C, Cafferty FH, Vale C, Langley RE.
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis.
Ann Oncol. 2016 Sep 28. pii: mdw410. [Epub ahead of print]
Source | Full text | Similar articles



.

Liu X, Li J, Schild SE, Schild MH, Wong W, Vora S, Herman MG, Fatyga M.
Statins and Metformin Use Is Associated with Lower PSA Levels in Prostate Cancer Patients Presenting for Radiation Therapy.
J Cancer Ther. 2017 Feb;8(2):73-85. doi: 10.4236/jct.2017.82007. Epub 2017 Feb 6.
Source | Full text | Similar articles



.

Zaidi S, Gandhi J, Joshi G, Smith NL, Khan SA.
The anticancer potential of metformin on prostate cancer.
Prostate Cancer Prostatic Dis. 2019 Jan 16. doi: 10.1038/s41391-018-0085-2. [Epub ahead of print]
Source | Full text | Similar articles



NUTRITION, AND DIETARY SUPPLEMENTS




OVERVIEW


.

Lin PH, Aronson W, Freedland SJ.
An update of research evidence on nutrition and prostate cancer.
Urol Oncol. 2017 Nov 2. pii: S1078-1439(17)30536-7. doi: 10.1016/j.urolonc.2017.10.006. [Epub ahead of print]
Source | Full text | Similar articles



.

Slade AN.
Prostate cancer and subsequent nutritional outcomes: the role of diagnosis and treatment.
J Cancer Surviv. 2019 Feb 7. doi: 10.1007/s11764-019-00739-z. [Epub ahead of print]
Source | Full text | Similar articles



.

Yacoubian A, Dargham RA, Khauli RB, Bachir BG.
Overview of Dietary Supplements in Prostate Cancer.
Curr Urol Rep. 2016 Nov;17(11):78. doi: 10.1007/s11934-016-0637-8.Epub 2016 Sep 9.
Source | Full text | Similar articles



.

Yedjou CG, Mbemi AT, Noubissi F, Tchounwou SS, Tsabang N, Payton M, Miele L, Tchounwou PB.
Prostate Cancer Disparity, Chemoprevention, and Treatment by Specific Medicinal Plants.
Nutrients. 2019 Feb 4;11(2). pii: E336. doi: 10.3390/nu11020336.
Source | Full text | Similar articles



BROCCOLI SPROUTS


.

Beaver LM, Lӧhr CV, Clarke JD, Glasser ST, Watson GW, Wong CP, Zhang Z, Williams DE, Dashwood RH, Shannon J, Thuillier P, Ho E.
Broccoli Sprouts Delay Prostate Cancer Formation and Decrease Prostate Cancer Severity with a Concurrent Decrease in HDAC3 Protein Expression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) Mice.
Curr Dev Nutr. 2018 Mar; 2(3): nzy002. doi: 10.1093/cdn/nzy002. eCollection 2018 Mar. Published online 2017 Dec 26.
Source | Full text | Similar articles



BOSWELLIA


.

Lu M, Xia L, Hua H, Jing Y.
Acetyl-keto-beta-boswellic acid induces apoptosis through a death receptor 5-mediated pathway in prostate cancer cells.
Cancer Res. 2008 Feb 15;68(4):1180-6. doi: 10.1158/0008-5472.CAN-07-2978.
Source | Full text | Similar articles



.

Pang X, Yi Z, Zhang X, Sung B, Qu W, Lian X, Aggarwal BB, Liu M.
Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
Cancer Res. 2009 Jul 15;69(14):5893-900. doi: 10.1158/0008-5472.CAN-09-0755. Epub 2009 Jun 30.
Source | Full text | Similar articles



.

Schmidt C, Loos C, Jin L, Schmiech M, Schmidt CQ, Gaafary ME, Syrovets T, Simmet T.
Acetyl-lupeolic acid inhibits Akt signaling and induces apoptosis in chemoresistant prostate cancer cells in vitro and in vivo.
Oncotarget. 2017 Jul 8;8(33):55147-55161. doi: 10.18632/oncotarget.19101. eCollection 2017 Aug 15.
Source | Full text | Similar articles



CALCIUM


.

Bernichtein S, Pigat N, Barry Delongchamps N, Boutillon F, Verkarre V, Camparo P, Reyes-Gomez E, Méjean A, Oudard SM, Lepicard EM, Viltard M, Souberbielle JC, Friedlander G, Capiod T, Goffin V.
Vitamin D3 Prevents Calcium-Induced Progression of Early-Stage Prostate Tumors by Counteracting TRPC6 and Calcium Sensing Receptor Upregulation.
Cancer Res. 2017 Jan 15;77(2):355-365. doi: 10.1158/0008-5472.CAN-16-0687. Epub 2016 Nov 22.
Source | Full text | Similar articles



.*

Fenner A.
Prostate cancer: Calcium promotes cancer; vitamin D decelerates.
Nat Rev Urol. 2017 Feb;14(2):68. doi: 10.1038/nrurol.2016.257. Epub 2016 Dec 6.
Source | Full text | Similar articles
Editorial referring to:
Bernichtein S et al., Vitamin D3 Prevents Calcium-Induced Progression of Early-Stage Prostate Tumors by Counteracting TRPC6 and Calcium Sensing Receptor Upregulation. Cancer Res. 2017 Jan 15;77(2):355-365. doi: 10.1158/0008-5472.CAN-16-0687. Epub 2016 Nov 22. Source / Full text



.

Rahmati S, Azami M, Delpisheh A, Hafezi Ahmadi MR, Sayehmiri K.
Total Calcium (Dietary and Supplementary) Intake and Prostate Cancer: a Systematic Review and Meta-Analysis
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1449-1456.
Source | Full text | Similar articles



.

Steck SE, Omofuma OO, Su LJ, Maise AA, Woloszynska-Read A, Johnson CS, Zhang H, Bensen JT, Fontham ETH, Mohler JL, Arab L.
Calcium, magnesium, and whole-milk intakes and high-aggressive prostate cancer in the North Carolina-Louisiana Prostate Cancer Project (PCaP).
Am J Clin Nutr. 2018 May 2; 107(5):799-807. doi: 10.1093/ajcn/nqy037.
Source | Full text | Similar articles



COFFEE


.

Lee AH, Binns CW.
Re: Coffee consumption and prostate cancer risk and progression in the health professionals follow-up study.
J Natl Cancer Inst. 2011 Oct 5;103(19):1481; author reply 1481-2. doi: 10.1093/jnci/djr305. Epub 2011 Aug 17.
Source | Full text | Similar articles



.

Polesel J, Zucchetto A, Talamini R, Dal Maso L, Serraino D, La Vecchia C, Franceschi S.
Re: coffee consumption and prostate cancer risk and progression in the health professional follow-up study.
J Natl Cancer Inst. 2012 Nov 7;104(21):1684-6; author reply 1686. doi: 10.1093/jnci/djs383. Epub 2012 Sep 6.
Source | Full text | Similar articles



.

Pounis G, Tabolacci C, Costanzo S, Cordella M, Bonaccio M, Rago L, D'Arcangelo D, Filippo Di Castelnuovo A, de Gaetano G, Donati MB, Iacoviello L, Facchiano F; Moli-sani study investigators.
Reduction by coffee consumption of prostate cancer risk: Evidence from the Moli-sani cohort and cellular models.
Int J Cancer. 2017 Jul 1;141(1):72-82. doi: 10.1002/ijc.30720. Epub 2017 Apr 24.
Source | Full text | Similar articles



.

Wilson KM, Kasperzyk JL, Rider JR, Kenfield S, van Dam RM, Stampfer MJ, Giovannucci E, Mucci LA.
Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study.
J Natl Cancer Inst. 2011 Jun 8;103(11):876-84. doi: 10.1093/jnci/djr151. Epub 2011 May 17
Source | Full text | Similar articles



CURCUMIN


.

Fabiani A, Morosetti C, Filosa A, Principi E, Lepri L, Maurelli V, Fioretti F, Servi L.
Effect on prostatic specific antigen by a short time treatment with a Curcuma extract: A real life experience and implications for prostate biopsy.
Arch Ital Urol Androl. 2018 Jun 30;90(2):107-111. doi: 10.4081/aiua.2018.2.107.
Source | Full text | Similar articles



.

Hejazi J, Rastmanesh R, Taleban FA, Molana SH, Hejazi E, Ehtejab G, Hara N.
Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study.
Nutr Cancer. 2016 Jan 15:1-9. [Epub ahead of print]
Source | Full text | Similar articles



.

Mandalapu D, Saini KS, Gupta S, Sharma V, Yaseen Malik M, Chaturvedi S, Bala V, Hamidullah, Thakur S, Maikhuri JP, Wahajuddin M, Konwar R, Gupta G, Sharma VL.
Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines.
Bioorg Med Chem Lett. 2016 Sep 1;26(17):4223-32. doi: 10.1016/j.bmcl.2016.07.053. Epub 2016 Jul 25.
Source | Full text | Similar articles



.

Mohebbati R, Anaeigoudari A, Khazdair MR.
The effects of Curcuma longa and curcumin on reproductive systems.
Endocr Regul. 2017 Oct 26;51(4):220-228. doi: 10.1515/enr-2017-0024.
Source | Full text | Similar articles



.

Rivera M, Ramos Y, Rodríguez-Valentín M, López-Acevedo S, Cubano LA, Zou J, Zhang Q, Wang G, Boukli NM.
Targeting multiple pro-apoptotic signaling pathways with curcumin in prostate cancer cells.
PLoS One. 2017 Jun 19;12(6):e0179587. doi: 10.1371/journal.pone.0179587. eCollection 2017.
Source | Full text | Similar articles



.

Sha J, Li J, Wang W, Pan L, Cheng J, Li L, Zhao H, Lin W.
Curcumin induces G0/G1 arrest and apoptosis in hormone independent prostate cancer DU-145 cells by down regulating Notch signaling.
Biomed Pharmacother. 2016 Sep 19;84:177-184. doi: 10.1016/j.biopha.2016.09.037. [Epub ahead of print]
Source | Full text | Similar articles



.

Yan J, Wang Y, Jia Y, Liu S, Tian C, Pan W, Liu X, Wang H.
Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
Biomed Pharmacother. 2017 Jan 22;88:374-383. doi: 10.1016/j.biopha.2016.12.138. [Epub ahead of print]
Source | Full text | Similar articles



.

Yang J, Wang C, Zhang Z, Chen X, Jia Y, Wang B, Kong T.
Curcumin inhibits the survival and metastasis of prostate cancer cells via the Notch-1 signaling pathway.
APMIS. 2017 Feb;125(2):134-140. doi: 10.1111/apm.12650. Epub 2017 Jan 24.
Source | Full text | Similar articles



FATTY ACIDS


.

Bassett JK, Severi G, Hodge AM, Macinnis RJ, Gibson RA, Hopper JL, English DR, Giles GG.
Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk.
Int J Cancer. 2013 Apr 11. doi: 10.1002/ijc.28203. [Epub ahead of print]
Source | Full text | Similar articles



.

Gevariya N, Besançon M, Robitaille K, Picard V, Diabaté L, Alesawi A, Julien P, Fradet Y, Bergeron A, Fradet V.
Omega-3 fatty acids decrease prostate cancer progression associated with an anti-tumor immune response in eugonadal and castrated mice.
Prostate. 2018 Aug 2. doi: 10.1002/pros.23706. [Epub ahead of print]
Source | Full text | Similar articles



.

Watt MJ, Clark AK, Selth LA, Haynes VR, Lister N, Rebello R, Porter LH, Niranjan B, Whitby ST, Lo J, Huang C, Schittenhelm RB, Anderson KE, Furic L, Wijayaratne PR, Matzaris M, Montgomery MK, Papargiris M, Norden S,
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer.
Sci Transl Med. 2019 Feb 6;11(478). pii: eaau5758. doi: 10.1126/scitranslmed.aau5758.
Source | Full text | Similar articles



FLAVONOIDS



Chiyomaru T, Yamamura S, Fukuhara S, Hidaka H, Majid S, Saini S, Arora S, Deng G, Shahryari V, Chang I, Tanaka Y, Tabatabai ZL, Enokida H, Seki N, Nakagawa M, Dahiya R.
Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate Cancer.
PLoS One. 2013;8(3):e58929. doi: 10.1371/journal.pone.0058929. Epub 2013 Mar 12.
Source | Full text | Similar articles



.

Tsai PH, Cheng CH, Lin CY, Huang YT, Lee LT, Kandaswami CC, Lin YC, Lee KP, Hung CC, Hwang JJ, Ke FC, Chang GD, Lee MT.
Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated Prostate Cancer Cells.
Anticancer Res. 2016 Dec;36(12):6367-6380.
Source | Full text | Similar articles



LEGUME INTAKE


.

Li J, Mao QQ.
Legume intake and risk of prostate cancer: a meta-analysis of prospective cohort studies.
Oncotarget. 2017 Apr 3. doi: 10.18632/oncotarget.16794. [Epub ahead of print]
Source | Full text | Similar articles



MEDITERRANEAN DIET


.

Bauer SR, Van Blarigan EL, Stampfer MJ, Chan JM, Kenfield SA.
Mediterranean diet after prostate cancer diagnosis and urinary and sexual functioning: The health professionals follow-up study.
Prostate. 2017 Dec 1. doi: 10.1002/pros.23457. [Epub ahead of print]
Source | Full text | Similar articles



.

Capurso C, Vendemiale G.
The Mediterranean Diet Reduces the Risk and Mortality of the Prostate Cancer: A Narrative Review.
Front Nutr. 2017 Aug 24;4:38. doi: 10.3389/fnut.2017.00038. eCollection 2017.
Source | Full text | Similar articles



.

Schneider L, Su LJ, Arab L, Bensen JT, Farnan L, Fontham ETH, Song L, Hussey J, Merchant AT, Mohler JL, Steck SE.
Dietary patterns based on the Mediterranean diet and DASH diet are inversely associated with high aggressive prostate cancer in PCaP.
Ann Epidemiol. 2018 Sep 5. pii: S1047-2797(18)30283-7. doi: 10.1016/j.annepidem.2018.08.012. [Epub ahead of print]
Source | Full text | Similar articles



MILK AND DAIRY PRODUCTS


.

Downer MK, Batista JL, Mucci LA, Stampfer MJ, Epstein MM, Håkansson N, Wolk A, Johansson JE, Andrén O, Fall K, Andersson SO.
Dairy intake in relation to prostate cancer survival.
Int J Cancer. 2017 Feb 10. doi: 10.1002/ijc.30642. [Epub ahead of print]
Source | Full text | Similar articles



.

Harrison S, Lennon R, Holly J, Higgins JPT, Gardner M, Perks C, Gaunt T, Tan V, Borwick C, Emmet P, Jeffreys M, Northstone K, Rinaldi S, Thomas S, Turner SD, Pease A, Vilenchick V, Martin RM, Lewis SJ.
Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis.
Cancer Causes Control. 2017 Jun;28(6):497-528. doi: 10.1007/s10552-017-0883-1. Epub 2017 Mar 30.
Source | Full text | Similar articles



.

Melnik BC.
Milk disrupts p53 and DNMT1, the guardians of the genome: implications for acne vulgaris and prostate cancer.
Nutr Metab (Lond). 2017 Aug 15;14:55. doi: 10.1186/s12986-017-0212-4. eCollection 2017.
Source | Full text | Similar articles



.

Thorning TK, Raben A, Tholstrup T, Soedamah-Muthu SS, Givens I, Astrup A.
Milk and dairy products: good or bad for human health? An assessment of the totality of scientific evidence.
Food Nutr Res. 2016 Nov 22;60:32527. doi: 10.3402/fnr.v60.32527.
Source | Full text | Similar articles



PHYTOESTROGENS


.

Reger MK, Zollinger TW, Liu Z, Jones JF, Zhang J.
Dietary intake of isoflavones and coumestrol and the risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Int J Cancer. 2017 Nov 8. doi: 10.1002/ijc.31095. [Epub ahead of print]
Source | Full text | Similar articles



.

Rietjens IM, Louisse J, Beekmann K.
The potential health effects of dietary phytoestrogens.
Br J Pharmacol. 2016 Oct 9. doi: 10.1111/bph.13622. [Epub ahead of print]
Source | Full text | Similar articles



POMEGRANATE


.

Deng Y, Li Y, Yang F, Zeng A, Yang S, Luo Y, Zhang Y, Xie Y, Ye T, Xia Y, Yin W.
The extract from Punica granatum (pomegranate) peel induces apoptosis and impairs metastasis in prostate cancer cells.
Biomed Pharmacother. 2017 Sep;93:976-984. doi: 10.1016/j.biopha.2017.07.008. Epub 2017 Jul 14.
Source | Full text | Similar articles



.

Paller CJ, Pantuck A, Carducci MA.
A review of pomegranate in prostate cancer.
Prostate Cancer Prostatic Dis. 2017 Apr 25. doi: 10.1038/pcan.2017.19. [Epub ahead of print]
Source | Full text | Similar articles



SELENIUM


.

Sayehmiri K, Azami M, Mohammadi Y, Soleymani A, Tardeh Z.
The association between Selenium and Prostate Cancer: a Systematic Review and Meta-Analysis
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1431-1437.
Source | Full text | Similar articles



SOY


.

Bosland MC, Kato I, Zeleniuch-Jacquotte A.
Soy protein and recurrence of prostate cancer--reply.
JAMA. 2013 Dec 4;310(21):2312-3. doi: 10.1001/jama.2013.278613.
Source | Full text | Similar articles



.

Bosland MC, Kato I, Zeleniuch-Jacquotte A, Schmoll J, Enk Rueter E, Melamed J, Kong MX, Macias V, Kajdacsy-Balla A, Lumey LH, Xie H, Gao W, Walden P, Lepor H, Taneja SS, Randolph C, Schlicht MJ, Meserve-Watanabe H, Deaton RJ, Davies JA.
Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.
JAMA. 2013 Jul 10;310(2):170-8. doi: 10.1001/jama.2013.7842.
Source | Full text | Similar articles



.

Fleshner NE, Kapusta L, Donnelly B, Tanguay S, Chin J, Hersey K, Farley A, Jansz K, Siemens DR, Trpkov K, Lacombe L, Gleave M, Tu D, Parulekar WR.
Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium.
Clin Oncol. 2011 Jun 10;29(17):2386-90. doi: 10.1200/JCO.2010.32.0994. Epub 2011 May 2.
Source | Full text | Similar articles



.

Messina M.
Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature.
Nutrients. 2016 Nov 24;8(12). pii: E754.
Source | Full text | Similar articles



.

Moyad MA.
Soy protein and recurrence of prostate cancer.
Comment on: Bosland MC et al, Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial. [JAMA. 2013 Jul 10].
JAMA. 2013 Dec 4;310(21):2311-2. doi: 10.1001/jama.2013.278601.
Source | Full text | Similar articles



.

Rayaprolu SJ, Hettiarachchy NS, Horax R, Phillips GK, Mahendran M, Chen P.
Soybean peptide fractions inhibit human blood, breast and prostate cancer cell proliferation.
J Food Sci Technol. 2017 Jan;54(1):38-44. doi: 10.1007/s13197-016-2426-2. Epub 2017 Jan 13.
Source | Full text | Similar articles



.

Taneja SS.
Re: effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial.
J Urol. 2014 Jan;191(1):74-6. doi: 10.1016/j.juro.2013.09.076. Epub 2013 Oct 4.
Source | Full text | Similar articles



.

Xiao Y, Zhang S, Tong H, Shi S.
Comprehensive evaluation of the role of soy and isoflavone supplementation in humans and animals over the past two decades.
Phytother Res. 2017 Nov 29. doi: 10.1002/ptr.5966. [Epub ahead of print]
Source | Full text | Similar articles



TEA


.

Hagen RM, Chedea VS, Mintoff CP, Bowler E, Morse HR, Ladomery MR.
Epigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3 prostate cancer cells.
Int J Oncol. 2013 Jul;43(1):194-200. doi: 10.3892/ijo.2013.1920. Epub 2013 Apr 24.
Source | Full text | Similar articles



VITAMIN D


.

Altundag K, Altundag O, Morandi P, Gunduz M.
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma.
Cancer. 2004 Sep 1;101(5):1101-2; author reply 1102-3. Epub 2004 Jul 16.
Source | Full text | Similar articles



.

Bernichtein S, Pigat N, Barry Delongchamps N, Boutillon F, Verkarre V, Camparo P, Reyes-Gomez E, Méjean A, Oudard SM, Lepicard EM, Viltard M, Souberbielle JC, Friedlander G, Capiod T, Goffin V.
Vitamin D3 prevents calcium-induced progression of early-stage prostate tumors by counteracting TRPC6 and calcium sensing receptor upregulation.
Cancer Res. 2016 Nov 22. pii: canres.0687.2016. [Epub ahead of print]
Source | Full text | Similar articles



.

Krajewski W, Dzięgała M, Kołodziej A, Dembowski J, Zdrojowy R.
Vitamin D and urological cancers.
Cent European J Urol. 2016;69(2):139-47. doi: 10.5173/ceju.2016.784. Epub 2016 Apr 19.
Source | Full text | Similar articles



.

Morris MJ, Smaletz O, Solit D, Kelly WK, Slovin S, Flombaum C, Curley T, Delacruz A, Schwartz L, Fleisher M, Zhu A, Diani M, Fallon M, Scher HI.
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma.
Cancer. 2004 May 1;100(9):1868-75. Epub 2004 Mar 31.
Source | Full text | Similar articles



.

Robles LA, Dawe K, Martin RM, Higgins JPT, Lewis SJ.
Does testosterone mediate the relationship between vitamin D and prostate cancer? A systematic review and meta-analysis protocol.
Syst Rev. 2019 Feb 12;8(1):52. doi: 10.1186/s13643-018-0908-1.
Source | Full text | Similar articles



.

Trump DL, Potter DM, Muindi J, Brufsky A, Johnson CS.
Phase II trial of high-dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen-independent prostate cancer.
Cancer.
2006 May 15;106(10):2136-42.
Source | Full text | Similar articles



VITAMIN K



Dasari S, Ali SM, Zheng G, Chen A, Dontaraju VS, Bosland MC, Kajdacsy-Balla A, Munirathinam G.
Vitamin K and its analogs: Potential avenues for prostate cancer management.
Oncotarget. 2017 May 19. doi: 10.18632/oncotarget.17997. [Epub ahead of print]
Source | Full text | Similar articles



WINE


.

Tenta R, Fragopoulou E, Tsoukala M, Xanthopoulou M, Skyrianou M, Pratsinis H, Kletsas D.
Antiproliferative Effects of Red and White Wine Extracts in PC-3 Prostate Cancer Cells.
Nutr Cancer. 2017 Jul 25:1-10. doi: 10.1080/01635581.2017.1340489. [Epub ahead of print]
Source | Full text | Similar articles



PHYSICAL ACTIVITY


.

Friedenreich CM, Wang Q, Neilson HK, Kopciuk KA, McGregor SE, Courneya KS.
Physical Activity and Survival After Prostate Cancer.
Eur Urol. 2016 Jan 7. pii: S0302-2838(15)01241-5. doi: 10.1016/j.eururo.2015.12.032. [Epub ahead of print]
Source | Full text | Similar articles



PREVENTION OF PROGRESSION


.

Demark-Wahnefried W.
Response to: systematic review of dietary, nutritional, and physical activity interventions for the prevention of prostate cancer progression and mortality by Hackshaw-McGeagh and Colleagues.
Cancer Causes Control. 2017 Jun 24. doi: 10.1007/s10552-017-0911-1. [Epub ahead of print]
Source | Full text | Similar articles



.

Dickerman BA, Ahearn TU, Giovannucci E, Stampfer MJ, Nguyen PL, Mucci LA, Wilson KM.
Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer.
Int J Cancer. 2017 Sep 1;141(5):933-944. doi: 10.1002/ijc.30803. Epub 2017 Jun 8.
Source | Full text | Similar articles



.

Gregg JR, Zheng J, Lopez DS, Reichard C, Browman G, Chapin B, Kim J, Davis J, Daniel CR.
Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillance.
Br J Cancer. 2019 Jan 25. doi: 10.1038/s41416-019-0380-2. [Epub ahead of print]
Source | Full text | Similar articles



.

Hackshaw-McGeagh LE, Perry RE, Leach VA, Qandil S, Jeffreys M, Martin RM, Lane JA.
A systematic review of dietary, nutritional, and physical activity interventions for the prevention of prostate cancer progression and mortality.
Cancer Causes Control. 2015 Nov;26(11):1521-50. doi: 10.1007/s10552-015-0659-4. Epub 2015 Sep 9.
Source | Full text | Similar articles



.

Mamouni K, Zhang S, Li X, Chen Y, Yang Y, Kim J, Bartlett MG, Coleman IM, Nelson PS, Kucuk O, Wu D.
A Novel Flavonoid Composition Targets Androgen Receptor Signaling and Inhibits Prostate Cancer Growth in Preclinical Models.
Neoplasia. 2018 Jul 4;20(8):789-799. doi: 10.1016/j.neo.2018.06.003. [Epub ahead of print]
Source | Full text | Similar articles



.

Mantzorou M, Koutelidakis A, Theocharis S, Giaginis C.
Clinical Value of Nutritional Status in Cancer: What is its Impact and how it Affects Disease Progression and Prognosis?
Nutr Cancer. 2017 Oct 30:1-26. doi: 10.1080/01635581.2017.1367947. [Epub ahead of print]
Source | Full text | Similar articles



.

Peisch SF, Van Blarigan EL, Chan JM, Stampfer MJ, Kenfield SA.
Prostate cancer progression and mortality: a review of diet and lifestyle factors.
World J Urol. 2016 Aug 12. [Epub ahead of print]
Source | Full text | Similar articles



.

Taneja SS.
Re: Weight Change, Obesity and Risk of Prostate Cancer Progression among Men with Clinically Localized Prostate Cancer.
J Urol. 2017 Nov;198(5):982. doi: 10.1016/j.juro.2017.08.036. Epub 2017 Aug 9.
Source | Full text | Similar articles



STATINS


.

Allott EH, Freeman MR, Freedland SJ.
Statin Therapy to Improve Prostate Cancer Outcomes: Who, When, and for How Long?
Eur Urol. 2018 Aug 31. pii: S0302-2838(18)30597-9. doi: 10.1016/j.eururo.2018.08.012. [Epub ahead of print]
Comment on: Murtola TJ et al, Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy-A Randomized, Double-blind, Placebo-controlled Clinical Trial. (Eur Urol. 2018 Jul 18).
Source | Full text | Similar articles



.

Allott EH, Farnan L, Steck SE, Song L, Arab L, Su LJ, Fontham ETH, Mohler JL, Bensen JT.
Statin use, high cholesterol and prostate cancer progression; results from HCaP-NC.
Prostate. 2018 May 1. doi: 10.1002/pros.23644. [Epub ahead of print]
Source | Full text | Similar articles



.

Bansal D, Undela K, D'Cruz S, Schifano F.
Statin use and risk of prostate cancer: a meta-analysis of observational studies.
PLoS One. 2012;7(10):e46691. doi: 10.1371/journal.pone.0046691. Epub 2012 Oct 1.
Source | Full text | Similar articles



.*

Camacho L, Zabala-Letona A, Carracedo A.
Re-evaluating statin activity in cancer.
Aging (Albany NY). 2018 Jul 22;10(7):1538-1539. doi: 10.18632/aging.101504.
Source | Full text | Similar articles



.

Chao C, Williams SG, Xu L, Chen J, Wallner LP, Porter KR, Jacobsen SJ.
Statin therapy is not associated with prostate cancer recurrence among patients who underwent radiation therapy.
Cancer Lett. 2013 Feb 15. doi:pii: S0304-3835(13)00129-8. 10.1016/j.canlet.2013.02.017. [Epub ahead of print]
Source | Full text | Similar articles



.

Chen YA, Lin YJ, Lin CL, Lin HJ, Wu HS, Hsu HY, Sun YC, Wu HY, Lai CH, Kao CH.
Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia.
Front Pharmacol. 2018 Mar 22;9:225. doi: 10.3389/fphar.2018.00225. eCollection 2018.
Source | Full text | Similar articles



.

Dawe DE, Ye X, Czaykowski P, Jassal D, Singh H, Skarsgard D, Aprikian A, Mahmud SM.
The effect of statin use on the incidence of prostate cancer: A population-based nested case-control study.
Int J Cancer. 2018 Feb 6. doi: 10.1002/ijc.31295. [Epub ahead of print]
Source | Full text | Similar articles



.

Fowke JH, Motley SS.
Statin Use Linked with a Decrease in the Conversion from High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) to Prostate Cancer.
Carcinogenesis. 2018 Apr 3. doi: 10.1093/carcin/bgy050. [Epub ahead of print]
Source | Full text | Similar articles



.

Freeman MR, Solomon KR.
Statin drugs and prostate cancer: time to consider proactive strategies in patients.
J Urol. 2013 Apr;189(4):1192-3. doi: 10.1016/j.juro.2013.01.033. Epub 2013 Jan 18
Comment on: Bansal D et al,Statin use and risk of prostate cancer: a meta-analysis of observational studies. [PLoS One. 2012;doi: 10.1371/journal.pone.0046691].
Source | Full text | Similar articles



.

Gutt R, Tonlaar N, Kunnavakkam R, Karrison T, Weichselbaum RR, Liauw SL.
Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.
J Clin Oncol. 2010 Jun 1;28(16):2653-9. doi: 10.1200/JCO.2009.27.3003. Epub 2010 Apr 26.
Source | Full text | Similar articles



.

Hamilton RJ.
Making Sense of the Statin-Prostate Cancer Relationship: Is It Time for a Randomized Controlled Trial?
Eur Urol Focus. 2016 Jun 23. pii: S2405-4569(16)30068-2. doi: 10.1016/j.euf.2016.06.008. [Epub ahead of print] Online 2016 Oct 17.
Source | Full text | Similar articles



.

Ingersoll MA, Miller DR, Martinez O, Wakefield CB, Hsieh KC, Simha MV, Kao CL, Chen HT, Batra SK, Lin MF.
Statin derivatives as therapeutic agents for castration-resistant prostate cancer.
Cancer Lett. 2016 Dec 1;383(1):94-105. doi: 10.1016/j.canlet.2016.09.008. Epub 2016 Sep 26.
Source | Full text | Similar articles



.

Kautzky-Willer A, Thurner S, Klimek P.
Use of statins offsets insulin-related cancer risk.
J Intern Med. 2016 Oct 21. doi: 10.1111/joim.12567. [Epub ahead of print]
Source | Full text | Similar articles



.

Larsen SB, Dehlendorff C, Skriver C, Dalton SO, Jespersen CG, Borre M, Brasso K, Nørgaard M, Johansen C, Sørensen HT, Hallas J, Friis S.
Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer.
J Clin Oncol. 2017 Aug 14:JCO2016718981. doi: 10.1200/JCO.2016.71.8981. [Epub ahead of print]
Source | Full text | Similar articles



.

Liu X, Li J, Schild SE, Schild MH, Wong W, Vora S, Herman MG, Fatyga M.
Statins and Metformin Use Is Associated with Lower PSA Levels in Prostate Cancer Patients Presenting for Radiation Therapy.
J Cancer Ther. 2017 Feb;8(2):73-85. doi: 10.4236/jct.2017.82007. Epub 2017 Feb 6.
Source | Full text | Similar articles



.

Lyon TD, Turner RM 2nd, Yabes JG, Woldemichael E, Davies BJ, Jacobs BL, Nelson JB.
Preoperative Statin Use at the Time of Radical Prostatectomy Is Not Associated With Biochemical Recurrence or Pathologic Upgrading.
Urology. 2016 Aug 8. pii: S0090-4295(16)30498-8. doi: 10.1016/j.urology.2016.08.004. [Epub ahead of print]
Source | Full text | Similar articles



.

Mucci LA, Kantoff PW.
Is the Evidence Sufficient to Recommend Statins for All Men With Prostate Cancer?
J Clin Oncol. 2017 Aug 17:JCO2017747915. doi: 10.1200/JCO.2017.74.7915. [Epub ahead of print]
Comment on: Larsen SB et al. (2017), Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer.
Source | Full text | Similar articles



.

Murtola TJ, Syvälä H, Tolonen T, Helminen M, Riikonen J, Koskimäki J, Pakarainen T, Kaipia A, Isotalo T, Kujala P, Tammela TLJ.
Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy-A Randomized, Double-blind, Placebo-controlled Clinical Trial.
Eur Urol. 2018 Jul 18. pii: S0302-2838(18)30465-2. doi: 10.1016/j.eururo.2018.06.037. [Epub ahead of print]
Source | Full text | Similar articles



.

Murtola TJ, Peltomaa AI, Talala K, Määttänen L, Taari K, Tammela TLJ, Auvinen A.
Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.
Eur Urol Focus. 2016 Jun 2. pii: S2405-4569(16)30052-9. doi: 10.1016/j.euf.2016.05.004. [Epub ahead of print] Online 2016 Oct 17.
Source | Full text | Similar articles



.

Raval AD, Thakker D, Negi H, Vyas A, Kaur H, Salkini MW.
Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
Prostate Cancer Prostatic Dis. 2016 Jun;19(2):151-62. doi: 10.1038/pcan.2015.58. Epub 2016 Jan 19.
Erratum in: Prostate Cancer Prostatic Dis. 2016 Jun;19(2):222. Kaur, H [added].
Source | Full text | Similar articles | Erratum



.

Schnoeller TJ, Jentzmik F, Schrader AJ, Steinestel J.
Influence of serum cholesterol level and statin treatment on prostate cancer aggressiveness.
Oncotarget. 2017 Apr 7. doi: 10.18632/oncotarget.16943. [Epub ahead of print]
Source | Full text | Similar articles



.

Tan P, Zhang C, Wei SY, Tang Z, Gao L, Yang L, Wei Q.
Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review.
Asian J Androl. 2016 Dec 2. doi: 10.4103/1008-682X.190327. [Epub ahead of print]
Source | Full text | Similar articles



.*

Thoma C.
Prostate cancer: Postdiagnosis statin use reduces mortality.
Nat Rev Urol. 2017 Aug 31. doi: 10.1038/nrurol.2017.146. [Epub ahead of print]
Comment on: Larsen SB et al. (2017), Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer.
Source | Full text | Similar articles



ANDROGEN DEPRIVATION THERAPY


.

Anderson-Carter I, Posielski N, Liou JI, Khemees TA, Downs TM, Abel EJ, Jarrard DF, Richards KA.
The impact of statins in combination with androgen deprivation therapy in patients with advanced prostate cancer: A large observational study.
Urol Oncol. 2019 Feb;37(2):130-137. doi: 10.1016/j.urolonc.2018.11.017. Epub 2018 Dec 7.
Source | Full text | Similar articles



CANCER AGGRESSIVENESS


.*

Caro-Maldonado A, Camacho L, Zabala-Letona A, Torrano V, Fernández-Ruiz S, Zamacola-Bascaran K, Arreal L, Valcárcel-Jiménez L, Martín-Martín N, Flores JM, Cortazar AR, Zúñiga-García P, Arruabarrena-Aristorena A, Guillaumond F, Cabrera D, Falcón-Perez JM, Aransay AM, Gomez-Muñoz A, Olivan M, Morote J, Carracedo A.
Low-dose statin treatment increases prostate cancer aggressiveness.
Oncotarget. 2017 Oct 31;9(2):1494-1504. doi: 10.18632/oncotarget.22217. eCollection 2018 Jan 5.
Source | Full text | Similar articles



CONCOMITANT USE OF ASPIRIN


.

He Y, Huang H, Farischon C, Li D, Du Z, Zhang K, Zheng X, Goodin S.
Combined effects of atorvastatin and aspirin on growth and apoptosis in human prostate cancer cells.
Oncol Rep. 2017 Feb;37(2):953-960. doi: 10.3892/or.2017.5353. Epub 2017 Jan 4.
Source | Full text | Similar articles



.

Ma Y, Brusselaers N.
Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk.
Prostate Cancer Prostatic Dis. 2017 Dec 19. doi: 10.1038/s41391-017-0021-x. [Epub ahead of print]
Source | Full text | Similar articles



CONCOMITANT USE OF CAFFEINE


.

Wang Z, Zhang L, Wan Z, He Y, Huang H, Xiang H, Wu X, Zhang K, Liu Y, Goodin S, Du Z, Zheng X.
Atorvastatin and Caffeine in Combination Regulates Apoptosis, Migration, Invasion and Tumorspheres of Prostate Cancer Cells.
Pathol Oncol Res. 2018 May 24. doi: 10.1007/s12253-018-0415-7. [Epub ahead of print]
Source | Full text | Similar articles



MORTALITY


.

Wu SY, Fang SC, Shih HJ, Wen YC, Shao YJ.
Mortality associated with statins in men with advanced prostate cancer treated with androgen deprivation therapy.
Eur J Cancer. 2019 Feb 28. pii: S0959-8049(19)30047-4. doi: 10.1016/j.ejca.2018.11.032. [Epub ahead of print]
Source | Full text | Similar articles



RECURRENCE


.

Chao C, Jacobsen SJ, Xu L, Wallner LP, Porter KR, Williams SG.
Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.
BJU Int. 2013 May;111(6):954-62. doi: 10.1111/j.1464-410X.2012.11639.x. Epub 2013 Mar 6.
Source | Full text | Similar articles



.

Kirby M.
Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.
BJU Int. 2013 May;111(6):854-6. doi: 10.1111/j.1464-410X.2012.11722.x. First published: 25 April 2013
Editorial. Refers to: Chao C et al, Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy. BJU Int. 2013 May;111(6):954-62. doi: 10.1111/j.1464-410X.2012.11639.x. Epub 2013 Mar 6.
Source | Full text | Similar articles



.

Park HS, Schoenfeld JD, Mailhot RB, Shive M, Hartman RI, Ogembo R, Mucci LA.
Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis.
Ann Oncol. 2013 Mar 18. https://doi.org/10.1093/annonc/mdt077 [Epub ahead of print]
Source | Full text | Similar articles



RT-RELATED RECTAL TOXICITY


.

Palumbo I, Matrone F, Montesi G, Bellavita R, Lupattelli M, Saldi S, Frattegiani A, Arena E, Mariucci C, Falcinelli L, Bini V, Aristei C.
Statins Protect Against Acute RT-related Rectal Toxicity in Patients with Prostate Cancer: An Observational Prospective Study.
Anticancer Res. 2017 Mar;37(3):1453-1457.
Source | Full text | Similar articles



Books




PDQ CANCER INFORMATION SUMMARIES


.

White J et al, PDQ Integrative, Alternative, and Complementary Therapies Editorial Board.
Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Patient Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US), 2017 Oct 31.
Source | Full text | Similar articles



.

White J et al, PDQ Integrative, Alternative, and Complementary Therapies Editorial Board.
Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Patient Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US), 2017 Feb 2.
Source | Full text | Similar articles